Literature DB >> 164899

31-P nuclear magnetic resonance studies on serum low and high density lipoproteins: effect of paramagnetic ion.

T O Henderson, A W Kruski, L G Davis, T Glonek, A M Scanu.   

Abstract

A paramagnetic quenching reagent, Mn-2+/EDTA (1:2.2), was developed for the purpose of investigating the phospholipid phosphate groupings of human serum low and high density lipoproteins through the quenching effect of the reagent on the 31-P nuclear magnetic resonance signals from these complexes. Systems investigated included native low and high density serum liproteins (LDL, HDL2, and HDL3), egg phosphatidylcholine vesicles together with appropriate phosphodiester model systems, diethyl phosphate in aqueous buffer, and phosphatidylcholine and sphingomyelin both in anhydrous methanol. The results of these studies indicated that ca. 50 percent of the phospholipid-phosphorus signal of LDL is quenched upon titration as compared to an 80-85 percent figure observed for HDL2 and HDL3. In all cases the spectral effects were totally reversible upon removalof the paramagnetic ion by dialysis. The results of the titration studies indicated a similar but not an identical behavior between HDL2 and HDL3. The results are consistent with model structures of HDL and LDL particles derived from low angle X-ray diffraction.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 164899     DOI: 10.1021/bi00680a017

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  2 in total

1.  The structure of plasma low density lipoproteins: experimental facts and interpretations--a minireview.

Authors:  T Kirchhausen; G Fless; A M Scanu
Journal:  Lipids       Date:  1980-06       Impact factor: 1.880

2.  A 31P nuclear magnetic resonance investigation of acyl group transfer from phosphatidylcholine to yield lysophosphatidylcholine in human plasma.

Authors:  M H Nouri-Sorkhabi; D R Sullivan; D C Roberts; P W Kuchel
Journal:  Lipids       Date:  1994-03       Impact factor: 1.880

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.